ERBB2 and breast cancer: By using MCF10A human breast cancer progression series (normal MCF10A >> cancerous CA1d), we found that cancer progression of this series was also linked to declines of basal BH4 and NO production (Fig. 1B) as well as the increases in the levels of HER2 and a proliferation marker Ki67 (12).